Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1993;87:874-880

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chester, A. H.
Right arrow Articles by Yacoub, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chester, A. H.
Right arrow Articles by Yacoub, M. H.

Circulation, Vol 87, 874-880, Copyright © 1993 by American Heart Association


ARTICLES

Interaction between thromboxane A2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries

AH Chester, SP Allen, S Tadjkarimi and MH Yacoub
National Heart and Lung Institute, Harefield Hospital, Middlesex, UK.

BACKGROUND. Platelets release two powerful vasoconstrictors-- thromboxane A2 (TXA2) and 5-hydroxytryptamine (5-HT). Animal studies have suggested that these two substances may act in a synergistic fashion to stimulate platelet activity and smooth muscle vasoconstriction. METHODS AND RESULTS. To assess the interaction between TXA2 and 5-HT at the individual 5-HT receptor subtypes reported to mediate contraction, the effect of the amine was determined in the presence of differing concentrations of the thromboxane mimetic U46619. A total of 168 vessel segments were removed from 20 recipient hearts of patients undergoing cardiac transplantation. Segments were set up in isolated organ baths and tested for their response to 5-HT in the presence of an EC10, EC30, or EC50 concentration of U46619 (n = 4). A synergistic response was only seen in a small number of the segments tested under these conditions. However, in the presence of ketanserin (10(-6) M) to block 5-HT2 receptors, there was a significant increase in the response to 10(-6) M 5-HT in the presence of both the EC30 (p < 0.025) and EC50 (p < 0.05) concentrations of U46619 (n = 4). The potentiation of non-5-HT2 receptor mediated responses to 5-HT, in the presence of U46619 (EC30), could be prevented by 10(-7) M methiothepin, a nonselective 5-HT1-like/5-HT2 receptor antagonist. CONCLUSIONS. These data indicate that TXA2 receptor activation can increase the response of 5-HT mediated by 5-HT1-like receptors in human coronary arteries. 5- HT1-like receptors have been shown to mediate the contractile effect of 5-HT in patients with variant and chronic stable angina. Thus, platelet contents may act together at specific receptor subtypes in the induction of myocardial ischemia.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
K. Leineweber, D. Bose, M. Vogelsang, M. Haude, R. Erbel, and G. Heusch
Intense Vasoconstriction in Response to Aspirate From Stented Saphenous Vein Aortocoronary Bypass Grafts
J. Am. Coll. Cardiol., March 7, 2006; 47(5): 981 - 986.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. J. Kelsall, A. H. Chester, M. Amrani, and D. R.J. Singer
C-Type Natriuretic Peptide Relaxes Human Coronary Artery Bypass Grafts Preconstricted by Endothelin-1
Ann. Thorac. Surg., October 1, 2005; 80(4): 1347 - 1351.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. W. Watts
5-Hydroxytryptamine-Induced Potentiation of Endothelin-1- and Norepinephrine-Induced Contraction Is Mitogen-Activated Protein Kinase Pathway Dependent
Hypertension, January 1, 2000; 35(1): 244 - 248.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
I. Reznik, Y. Rosen, and B. Rosen
An acute ischaemic event associated with the use of venlafaxine: a case report and proposed pathophysiological mechanisms
J Psychopharmacol, March 1, 1999; 13(2): 193 - 195.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
T. Ishida, K.-i. Hirata, T. Sakoda, S. Kawashima, H. Akita, and M. Yokoyama
Identification of mRNA for 5-HT1 and 5-HT2 receptor subtypes in human coronary arteries
Cardiovasc Res, January 1, 1999; 41(1): 267 - 274.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. MaassenVanDenBrink, M. Reekers, W. A. Bax, M. D. Ferrari, and P. R. Saxena
Coronary Side-Effect Potential of Current and Prospective Antimigraine Drugs
Circulation, July 7, 1998; 98(1): 25 - 30.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L.-W. Fu and J. C Longhurst
Role of 5-HT3 receptors in activation of abdominal sympathetic C fibre afferents during ischaemia in cats
J. Physiol., June 15, 1998; 509(3): 729 - 740.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Kadokami, K. Egashira, K. Kuwata, Y. Fukumoto, T. Kozai, H. Yasutake, T. Kuga, H. Shimokawa, K. Sueishi, and A. Takeshita
Altered Serotonin Receptor Subtypes Mediate Coronary Microvascular Hyperreactivityin Pigs With Chronic Inhibitionof Nitric Oxide Synthesis
Circulation, July 15, 1996; 94(2): 182 - 189.
[Abstract] [Full Text]